Close Menu
Home » Large Pan-Cancer CRISPR Screens by Broad, Sanger Institutes Show High Concordance

Large Pan-Cancer CRISPR Screens by Broad, Sanger Institutes Show High Concordance

Dec 20, 2019
|
staff reporter

NEW YORK – Researchers from the Broad Institute and the Wellcome Sanger Institute have found that results from two pan-cancer CRISPR-Cas9 screens recently published by the institutes were highly concordant across multiple metrics despite significant differences in experimental protocols and reagents.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Letter Condemns Virus Conspiracy Theories

At the Lancet, more than two dozen public health researchers condemn the conspiracy theories that have emerged surrounding the source of the COVID-19 outbreak.

Philip Leder Dies

The Washington Post reports that Philip Leder, who helped uncover how DNA codes for proteins and studied the role of genes in cancer, has died.

New and Maybe Important

Researchers from Trinity College Dublin and the University of Pittsburgh look into how often de novo genes arise and how important they may be.

Nucleic Acids Research Studies on Alu Genotyping, Stress Response Histones, Undocumented Small RNAs

In Nucleic Acids Research this week: pipeline for genotyping Alu retrotransposon mobile element insertions, previously undocumented non-coding RNAs, and more.

Feb
26
Featured Webinar

Transformation of the Lab to Fight Genetic Illnesses in the Amish and Mennonite Populations

Sponsored by
Autogen

This webinar will explain how the Clinic for Special Children in Strasburg, Pennsylvania, has transformed its DNA workflows to improve the diagnosis and treatment of genetic illnesses that are prevalent in the pediatric population of its community.

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.